Prodigy tracks new-to-market drugs approved by the U.S. Food and Drug Administration (FDA). While the pipeline report includes all novel drugs that may or may not be currently indicated for conditions covered under workers’ compensation, it provides claims professionals with background information that could be useful if/when these products are prescribed for indicated conditions or off-label use.
4Q2023 FDA New Drug Approvals
Previous
Previous
4Q23 Top 10 Drugs and Therapy Classes
Next
Next

